COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Trial of Afatinib in Pediatric Tumours

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02372006
Recruitment Status : Suspended (Due to the current COVID-19 pandemic, the recruitment of new subjects is temporarily discontinued. Ongoing, randomised patients are managed per Trial Protocol.)
First Posted : February 26, 2015
Last Update Posted : April 8, 2020
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : April 21, 2020
Estimated Study Completion Date : May 22, 2020